Plandai Biotechnology (Plandai Biotechnology) Total Stockholders Equity : $-0.44 Mil (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology Total Stockholders Equity?

Plandai Biotechnology's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $-0.44 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Plandai Biotechnology's Book Value per Share for the quarter that ended in Jun. 2023 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Plandai Biotechnology's Debt-to-Equity for the quarter that ended in Jun. 2023 was -0.11.

Plandai Biotechnology Total Stockholders Equity Historical Data

The historical data trend for Plandai Biotechnology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology Total Stockholders Equity Chart

Plandai Biotechnology Annual Data

Trend

Mar09

Mar10

Mar11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

-2.78

-6.54

-9.80

-1.53

-0.44

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial											-2.78	-6.54	-9.80	-1.53	-0.44

Plandai Biotechnology (OTCPK:PLPL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Plandai Biotechnology's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.443	-	0)	/	8199.03
	=	-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Plandai Biotechnology's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.05	+	0)	/	-0.443
	=	-0.11

Plandai Biotechnology Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Plandai Biotechnology (Plandai Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4811 49th Street, San Diego, CA, USA, 92115

Website

http://www.plandaibiotech.com

Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.

Executives

Callum Baylis-duffield	director	FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula	other: Former Director	175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson	director	P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield	director, officer: President, Secretary and CFO	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield	director	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki	director	21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866